| Preferred Name |
Ilorasertib |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116729 |
| CAS_Registry |
1227939-82-3 |
| code |
C116729 |
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157712 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C177537 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 |
| Contributing_Source |
CTRP GDC FDA |
| DEFINITION |
An orally bioavailable, adenosine triphospate mimetic, and inhibitor of Aurora kinases, vascular endothelial growth factor receptors (VEGFRs) and platelet-derived growth factor receptor (PDGFRs), with potential antineoplastic activity. Upon administration, ilorasertib selectively binds to and inhibits Aurora kinases A, B and C, which may disrupt both the assembly of the mitotic spindle apparatus and chromosome segregation, and inhibit both cellular division and proliferation in Aurora kinase-overexpressing tumor cells. In addition, ilorasertib selectively binds to and inhibits VEGFRs and PDGFRs, which may result in the inhibition of both angiogenesis and tumor cell proliferation in VEGFR/PDGFR-overexpressing tumor cells. This agent also inhibits the Src family of cytoplasmic tyrosine kinases. Aurora kinases A, B and C, are serine/threonine kinases that play essential roles in mitotic checkpoint control and are overexpressed by a wide variety of tumor cell types. Both VEGFRs and PDGFRs are receptor tyrosine kinase families whose members may be upregulated in various tumor cell types. |
| Display_Name |
Ilorasertib |
| FDA_UNII_Code |
6L5D03D975 |
| FULL_SYN |
A-968660.0 ILORASERTIB 1-(4-(4-Amino-7-(1-(2-hydroxyethyl)-1H-pyrazol-4-yl)thieno[3,2-c]pyridin-3-yl)phenyl)-3-(3-fluorophenyl)urea Ilorasertib ABT-348 |
| Has_Target |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C30006 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C17293 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C68596 |
| Is_Value_For_GDC_Property | |
| label |
Ilorasertib |
| Maps_To |
Ilorasertib |
| NCI_Drug_Dictionary_ID |
672556 |
| PDQ_Closed_Trial_Search_ID |
672556 |
| PDQ_Open_Trial_Search_ID |
672556 |
| Preferred_Name |
Ilorasertib |
| prefixIRI |
Thesaurus:C116729 |
| prefLabel |
Ilorasertib |
| Semantic_Type |
Pharmacologic Substance |
| UMLS_CUI |
C3660880 |
| subClassOf |
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| http://purl.bioontology.org/ontology/MESH/C577638 | Medical Subject Headings / 医学主题词表 | LOOM |